|
The 10 Most Frequent AEs (Safety Population) |
|||
| Lumiracoxib 100 mg o.d. (n = 755) |
Lumiracoxib 100 mg b.i.d. (n = 1,519) |
Celecoxib 200 mg o.d. (n = 758) |
|
|
|
|||
| Headache |
82 (10.9) |
174 (11.5) |
82 (10.8) |
| Nasopharyngitis |
80 (10.6) |
141 (9.3) |
75 (9.9) |
| Back pain |
46 (6.1) |
87 (5.7) |
52 (6.9) |
| Arthralgia |
53 (7.0) |
82 (5.4) |
41 (5.4) |
| Abdominal pain upper |
42 (5.6) |
88 (5.8) |
35 (4.6) |
| Upper respiratory tract infection |
36 (4.8) |
86 (5.7) |
43 (5.7) |
| Dyspepsia |
38 (5.0) |
85 (5.6) |
39 (5.1) |
| Urinary tract infection |
38 (5.0) |
75 (4.9) |
24 (3.2) |
| Sinusitis |
21 (2.8) |
58 (3.8) |
34 (4.5) |
| Influenza |
30 (4.0) |
53 (3.5) |
28 (3.7) |
|
o.d. = once daily; b.i.d. = twice daily. | |||
Fleischmann et al. BMC Musculoskeletal Disorders 2008 9:32 doi:10.1186/1471-2474-9-32 |
|||